Showing results (1191-1200 of 1,368) with videos related to

Sort By:
Pageof 137
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Arquivos Brasileiros De Cirurgia Digestiva : ABCD = Brazilian Archives of Digestive Surgery|March 8, 2018
DIAGNOSTIC VALUE OF C-REACTIVE PROTEIN AND THE INFLUENCE OF VISCERAL FAT IN PATIENTS WITH OBESITY AND ACUTE APPENDICITISAdham do Amaral E Castro, Thelma Larocca Skare, Fernando Ide Yamauchi, et al.
Haematologica|January 8, 2010
Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trialAntonio Palumbo, Alessandra Larocca, Mariella Genuardi, et al.
Clinical Epigenetics|January 9, 2019
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agentsRiccardo Ricci, Maurizio Martini, Gloria Ravegnini, et al.
Oncoimmunology|December 20, 2016
Impaired functional responses in follicular lymphoma CD8<sup>+</sup>TIM-3<sup>+</sup> T lymphocytes following TCR engagementPauline Gravelle, Catherine Do, Camille Franchet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis FungoidesJohn T O'Malley, Adele de Masson, Elizabeth L Lowry, et al.
Cancer Cytopathology|March 28, 2023
p53 expression in cytology samples may represent a marker of early-stage cancerFederica Policardo, Pietro Tralongo, Damiano Arciuolo, et al.
Hypertension (Dallas, Tex. : 1979)|July 30, 2019
Maternal Cardiovascular Dysregulation During Early Pregnancy After In Vitro Fertilization Cycles in the Absence of a Corpus LuteumKirk P Conrad, John W Petersen, Yueh-Yun Chi, et al.
Leukemia & Lymphoma|May 26, 2010
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match studyMassimo Offidani, Pietro Leoni, Sara Bringhen, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Pageof 137